banner
Reference Listed Drugs
IMBRUVICA 140mg Ibrutinib Capsules Reference Listed Drug

IMBRUVICA 140mg Ibrutinib Capsules Reference Listed Drug

Patients with mantle cell lymphoma (MCL) who have received at least one prior treatment. For R&D purposes only.

Product Details

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

 

Generic name Ibrutinib Capsules
Trade name IMBRUVICA
Specification 140mg
Main ingredients Ibrutinib
Appearance White opaque hard gelatin capsule No. 0 printed in black ink with the words "ibr140mg", the contents of which are white or white like powder.
MA Holder Janssen-Cilag International NV
Manufacturer Catalent CTS LLC
Product Type Reference Listed Drugs (RLDs)

 

 

 

Indications:
1. Patients with mantle cell lymphoma (MCL) who have received at least one prior treatment;
2. Treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) patients;
3. Patients with Fahrenheit macroglobulinemia should be treated according to the drug label.

 

 

 

IMBRUVICA

 

 

 

For more details,pls contact Janney:

Email: tosun-global@upharm.cn

Wechat/Whatsapp:(+86)18922120575

 

 

Hot Tags: IMBRUVICA 140mg Ibrutinib Capsules Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Alfacalcidol Soft Capsules, Adefovir Dipivoxil Tablets, Phenytoin Sodium Tablets, Argatroban Injection, Acarbose Tablets, Agomelatine Tablets

Send Inquiry
Verification Code: